爱尔兰基层医疗高风险处方趋势与变异
本研究基于爱尔兰全国药房理赔数据库,采用共识验证指标分析2011至2015年社区成人高风险处方(HRP)的流行趋势、相关因素及全科医生与药房间的变异。结果显示多数HRP指标显著下降,但部分指标仍持续存在;HRP随年龄和慢性用药数量增加而上升,且全科医生处方率与药房配药率均存在显著变异。
要点
- 2011至2015年多数HRP指标显著下降(P<0.001),但部分指标仍持续存在。
- 2015年HRP率最高的指标包括≥75岁用NSAID无胃保护、华法林与抗血小板药或高风险抗生素联用等。
- HRP随年龄和慢性用药数量增加而显著上升,全科医生与药房层面均存在显著变异。
核心结论
- 爱尔兰社区高风险处方总体下降,但部分指标仍持续存在。
- 全科医生处方率与药房配药率均存在显著变异,提示安全用药有改善空间。
研究设计与样本
- 重复横断面全国药房理赔数据库研究,使用共识验证的处方指标。
- 采用多水平logistic回归分析HRP及配药相关因素。
主要发现
- 2015年HRP率最高的指标:≥75岁用NSAID无胃保护占37.2%,华法林联用抗血小板药占19.5%,华法林联用高风险抗生素占16.2%,≥65岁用地高辛≥250μg/天占14.0%。
- HRP随年龄和慢性用药数量增加而显著上升(P<0.001)。
- 控制患者变量后,全科医生间HRP率变异显著(P<0.05);进一步控制处方医生后,药房间高风险处方配药率变异显著(P<0.05)。
临床怎么用
- 关注老年及多重用药患者的高风险处方,尤其NSAID无胃保护、华法林联用抗血小板药或高风险抗生素、高剂量地高辛等。
- 全科医生与药房层面的显著变异提示可通过针对性干预提升社区安全用药。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The aims of the present study were to examine the prevalence of high-risk prescribing (HRP) in community-dwelling adults in Ireland from 2011-2015 using consensus-validated indicators, factors associated with HRP, and the variation in HRP between general practitioners (GPs) and in the dispensing of high-risk prescriptions between pharmacies. METHODS: A repeated cross-sectional national pharmacy claims database study was conducted. Prescribing indicators were based on those developed in formal consensus studies and applicable to pharmacy claims data. Multilevel logistic regression was used to examine factors associated with HRP and dispensing. RESULTS: There were significant reductions in the rates of most indicators over time (P < 0.001). A total of 66 022 of 300 906 patients at risk in 2011 [21.9%, 95% confidence interval (CI) 21.8, 22.1%], and 42 109 of 278 469 in 2015 (15.1%, 95% CI 15.0, 15.3%), received ≥1 high-risk prescription (P < 0.001). In 2015, indicators with the highest rates of HRP were prescription of a nonsteroidal anti-inflammatory drug (NSAID) without gastroprotection in those ≥75 years (37.2% of those on NSAIDs), coprescription of warfarin and an antiplatelet agent or high-risk antibiotic (19.5% and 16.2% of those on warfarin, respectively) and prescription of digoxin ≥250 μg day-1 in those ≥65 years (14.0% of those on digoxin). Any HRP increased significantly with age and number of chronic medications (P < 0.001). a) After controlling for patient variables, the variation in the rate of HRP between GPs was significant (P < 0.05); and b) after controlling for patient variables and the prescribing GP, the variation in the rate of dispensing of high-risk prescriptions between pharmacies was significant (P < 0.05). CONCLUSIONS: HRP in Ireland has declined over time, although some indicators persist. The variation between GPs and pharmacies suggests the potential for improvement in safe medicines use in community care, particularly in vulnerable older populations.
引用
- Byrne CJ, Cahir C, Curran C, et al. High-risk prescribing in an Irish primary care population: trends and variation. Br J Clin Pharmacol. 2017. PMID: 28701029. doi:10.1111/bcp.13373
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。